Falah M Al-Rekabi

Falah M Al-Rekabi

Auto-generated profile, based on publicly available information

Falah M Al-Rekabi

Department of Physiology, Biochemistry and Pharmacology, College of Veterinary Medicine, University of Baghdad, Baghdad, Iraq

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2023 in The Iraqi Journal of Veterinary Medicine
Verified
Journal Article
Open access
PDF file
SHSuhad H Hashem
Suhad H Hashem
FAFalah M. K. Al-Rekabi
Falah M. K. Al-Rekabi
SASelman Ali
Selman Ali
Acetaminophen (N-acetyl-para-aminophenol, APAP), widely used for pain relief across specie, poses significant toxicity risks. This study ‎aimed to assess the acute toxicity profile of APAP by determining the median toxic dose ‎‎(TD50) in a ‎‎murine model. Sixty male Balb/c mice, aged 8 weeks and weighing 20-30 ‎g, were randomized into six equal groups. Five groups received single oral doses of APAP (150, 200, 300, 500, and 700 mg/kg BW), while the control group received distilled water. The TD50 was ‎computed utilizing the probit method. Animals were ‎‎monitored for 24 h for ‎any sign indicative of clinical toxicity. Post-exposure, liver and kidney necropsies were conducted for histopathological analysis. Predominant symptoms of toxicity included prostration, hematuria, heightened agitation, lacrimation, cyanosis, and recumbency across doses from 150 to 700 mg/kg BW. The TD50 for APAP was estimated to be 732 ‎mg/kg BW. The liver histopathological examination of mice treated ‎‎with 700 mg/kg BW APAP ‎revealed severe multifocal hyper eosinophilic hepatocytes, indicating areas of centrilobular ‎necrosis, disorganized ‎‎hepatic cords, and multiple hemorrhage regions. The kidney ‎examination exhibited no pathological changes in treated mice with 700 mg/kg BW ‎‎APAP. In ‎conclusion this investigation provides critical insights into the acute toxicity profile of APAP. The findings not only highlight the ‎‎potential risk associated with APAP usage but also the ‎necessity of strict monitoring for stringent dosage control. Further research is also ‎‎needed to ‎understand the underlying mechanism of APAP-induced toxicity and pave the way for the ‎development of efficacious therapeutic ‎strategies to counter APAP overdose‎‎‎‎.

28 June 2023 in The Iraqi Journal of Veterinary Medicine
Verified
Journal Article
Open access
PDF file
AAAli I Al-Ameedi
Ali I Al-Ameedi
FAFalah M Al-Rekabi
Falah M Al-Rekabi
In the treatment of COVID-19, the antiviral medication Favipiravir has proven to be quite successful. Its metabolism is mediated by the enzymes aldehyde oxidase (AO) and xanthine oxidase (XO). This research investigated the potential drug-drug interaction betweenfavipiravir and amlodipine in hypertensive rabbits. Twenty local adult male rabbits (aged between 10 and 12 months and weighing between 2 and 2.5 kg) were induced with hypertension by 20 mg/kg BW of desoxycorticosterone acetate subcutaneously for three weeks and then divided randomly into two groups of ten. The first group received a single oral dose of 40 mg/kg BW of favipiravir, while the second group received 5 mg/kg of amlodipine orally for 14 consecutive days to inhibit AO before receiving a single oral dose of 40 mg/kg BW of favipiravir. Blood samples were collected from the marginal ear vein at 15, 30, 45 min, and 1, 2, 4, 8, 12, 24, 48, 36, 48, and 72 h. High-performance liquid chromatography (HPLC) was used to determine the concentration of favipiravir in the plasma. The results showed that co-administration of amlodipine prolonged the time taken for favipiravir (Tmax) to reach maximum plasma concentration (Cmax) and decreased its elimination half-life, while increasing the area under the curve (AUC). Amlodipine also prolonged the elimination of favipiravir by reducing the clearance per unit time (Cl/f). Additionally, hypertension potentiated the effect of amlodipine on the absorption, distribution, metabolism, and excretion of favipiravir. In conclusion, concomitant use of favipiravir with other drugs that affect AO enzyme activity may alter the pharmacokinetic profile of the drug. Therefore, adjusting the dose of favipiravir administered to hypertensive patients receiving amlodipine is recommended.

28 December 2022 in The Iraqi Journal of Veterinary Medicine
Verified
Journal Article
Open access
PDF file
MTMohammed K Tarab
Mohammed K Tarab
FAFalah M Al-Rekabi
Falah M Al-Rekabi
Colorectal cancer ranks as the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths globally. ‎Fluoroquinolones, particularly Levofloxacin, have garnered interest for their potential anti-cancer effects, primarily due to their high affinity ‎for metallic ions like copper. This affinity enhances their spectrum of activity and enables greater interaction with DNA in cancer cells, ‎thereby inhibiting proliferation. Building on our prior work, where we synthesized copper-modified Levofloxacin (MOLVX), this study ‎explores its therapeutic potential in treating precancerous colorectal lesions, known as Aberrant Crypt Foci (ACF), in a murine model. Sixty ‎female Balb-C mice were randomized into six groups (n=10 per group). The first group served as a negative control and received no treatment. ‎The remaining groups were administered azoxymethane (AOM) at 10 mg/kg body weight (BW) twice weekly to induce ACF. Among these, the ‎second group acted as a positive control and received no further treatment. The third group was intraperitoneally administered doxorubicin at ‎‎16.2 mg/kg BW once a week for four weeks. The fourth group was treated with Levofloxacin at 25 mg/kg BW via oral lavage daily for four ‎weeks. The final two groups received daily oral lavage treatments of MOLVX at doses of 5 mg/kg and 2.5 mg/kg BW for four weeks, ‎respectively. Histopathological analysis of ACF tissues, stained with hematoxylin and eosin, revealed a statistically significant reduction ‎‎(P<0.05) in ACF count among groups treated with MOLVX, doxorubicin, and Levofloxacin, compared to the positive control. Additionally, both ‎MOLVX-treated groups showed a significant decrease (P<0.05) in proliferating cellular antigen (PCNA) levels. In conclusion, both MOLVX ‎dosages (2.5 mg/kg and 5 mg/kg BW) demonstrated promising therapeutic efficacy against precancerous colorectal lesions in mice. However, ‎the 5 mg/kg BW dose appeared to be more potent.

28 June 2023 in The Iraqi Journal of Veterinary Medicine
Verified
Journal Article
Open access
PDF file
MKMariam A Kadhem
Mariam A Kadhem
FAFalah M Al-Rekabi
Falah M Al-Rekabi
SSamah A. Jassam
Samah A. Jassam
This study aimed to determine the effect of an ethanolic extract of Salvia hispanica‎ (Sh) seeds on ‎osteoporosis induced by methylprednisolone (MP) in female rabbits by assessing the bone ‎mineral density (BMD), serum levels of calcium, phosphorus, vitamin D, and parathyroid ‎hormone, as well as histopathological changes in the femur bone. Fifty female rabbits ‎‎(Lepus cuniculus) averaging 1800±125 g and 8±1.4 months old were used in this study. ‎They were randomly allocated to five groups of 10 rabbits each. The negative control group ‎received only subcutaneous normal saline (1 mL/kg BW). The positive control group received MP subcutaneously at a dose of 0.2 mg/kg BW per ‎day for 30 days, followed by oral normal saline (1 mL/kg BW) per day for two months. ‎Group 3 received MP followed by oral administration of Sh seed ethanolic extract at a dose of 600 mg/kg BW per day for two months. Group 4 received MP followed by oral administration of alendronate (Ale) at a dose ‎of 3.6 mg/kg weekly for two months. Group 5 received MP ‎followed by Ale and then Sh seed ethanolic extract. The study continued until one ‎week after the cessation of the treatments. The results showed that the BMD and serum ‎concentrations of calcium, phosphorus, and vitamin D significantly decreased (P<0.05), ‎while serum concentrations of parathyroid hormone significantly increased (P<0.05) in the ‎positive control and alendronate groups compared with the negative control group after two ‎months of treatment and after one week of withdrawal. However, the administration of Sh methanolic extract to the animals in the three treatment groups ‎ameliorated these parameters and reverted them to normal values. Histopathological ‎analysis of the femur bone head revealed abnormal bone morphology in the positive control ‎group, while Sh extract treatment preserved the normal histology in the other ‎groups. These findings concluded to that Sh seeds ethanolic extract has the ‎potential to prevent bone loss induced by chronic glucocorticoid therapy and may have ‎significant implications for the treatment of osteoporosis.